ClinicalTrials.govpublic full text
Atrasentan in Patients With Proteinuric Glomerular Diseases
iga nephropathy, focal segmental glomerulosclerosis, alport syndrome, diabetic kidney disease, diabetic nephropathy type 2, immunoglobulin a nephropathy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847953
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.